United States Pharmaceuticals

Assertio Holdings Inc (ASRT)

Ticker: ASRT Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Assertio Holdings Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Stark David Matthew Non-Executive Director
Transaction date
Planned sale
Price
219.41
Quantity 50,974 +0.4%
Value US$3,945,441
DAVID STARK Director Non-Executive Director
Transaction date
Proposed sale
Price
55.51
Quantity 73,023
Value US$256,302
4.0
Mason Heather L Non-Executive Director
Transaction date
Purchase
Price
374.93
Quantity 90,680 +16.4%
Value US$848,751
2.2
O'Grady Brendan P. CEO Executive Director
Transaction date
Purchase
Price
0.85
Quantity 11,706 New position
Value US$9,950
3.7
Vacirca Jeff L Non-Executive Director
Transaction date
Purchase
Price
1.11
Quantity 10,000 +7.1%
Value US$11,100
4.0
Mason Heather L Interim Executive Officer Executive Director
Transaction date
Purchase
Price
0.97
Quantity 25,000 +13.3%
Value US$24,250
3.3
Tyree James L Non-Executive Director
Transaction date
Sale
Price
1.12
Quantity 10,251 -5.2%
Value US$11,463
3.3
Tyree James L Director Non-Executive Director
Transaction date
Proposed sale
Price
1.12
Quantity 10,251
Value US$11,463
3.3
Peisert Daniel A. President & CEO Executive Director
Transaction date
Sale
Price
2.97
Quantity 31,121 -8.7%
Value US$92,432
3.3
Daniel A Peisert Officer Officer
Transaction date
Proposed sale
Price
3.01
Quantity 31,121
Value US$93,674
3.3
Schlessinger Sam SVP, General Counsel Officer
Transaction date
Sale
Price
3.04
Quantity 45,236 -39.6%
Value US$137,441
3.3
Schwichtenberg Paul SVP and CFO Officer
Transaction date
Sale
Price
3.07
Quantity 104,980 -62.0%
Value US$322,593
2.7
Patel Ajay SVP and CAO Officer
Transaction date
Sale
Price
3.04
Quantity 64,313 -40.7%
Value US$195,794
3.3
Peisert Daniel A. President & CEO Executive Director
Transaction date
Sale
Price
3.04
Quantity 127,281 -26.3%
Value US$386,972
2.7
Patel Ajay Officer Officer
Transaction date
Proposed sale
Price
3.17
Quantity 64,313
Value US$203,872
3.3
SAM SCHLESSINGER Officer Officer
Transaction date
Proposed sale
Price
3.04
Quantity 45,236
Value US$137,441
3.3
DANIEL PEISERT Officer Officer
Transaction date
Proposed sale
Price
3.04
Quantity 127,281
Value US$386,972
3.3
PAUL SCHWICHTENBERG Officer Officer
Transaction date
Proposed sale
Price
3.07
Quantity 104,980
Value US$322,593
MCKEE WILLIAM Non-Executive Director
Transaction date
Planned sale
Price
3.14
Quantity 22,000 -8.4%
Value US$69,045
WILLIAM MCKEE Director Non-Executive Director
Transaction date
Proposed sale
Price
3.14
Quantity 22,000
Value US$69,045
4.0
Mason Heather L Non-Executive Director
Transaction date
Sale
Price
7.30
Quantity 89,286 -32.2%
Value US$652,011
4.0
Mason Heather L Director Non-Executive Director
Transaction date
Proposed sale
Price
7.30
Quantity 89,286
Value US$651,788
3.3
JAMES TYREE Director Non-Executive Director
Transaction date
Proposed sale
Price
6.00
Quantity 43,143
Value US$258,767
3.3
Tyree James L Non-Executive Director
Transaction date
Planned sale
Price
6.00
Quantity 43,143 -20.5%
Value US$258,767
MCKEE WILLIAM Non-Executive Director
Transaction date
Planned sale
Price
2.35
Quantity 22,322 -8.9%
Value US$52,488
3.3
Tyree James L Non-Executive Director
Transaction date
Planned sale
Price
2.36
Quantity 44,643 -17.5%
Value US$105,170
3.3
Peisert Daniel A. President and CEO Executive Director
Transaction date
Planned sale
Price
3.50
Quantity 26,391 -14.3%
Value US$92,368
3.3
Peisert Daniel A. President and CEO Executive Director
Transaction date
Planned sale
Price
3.50
Quantity 34,518 -15.7%
Value US$120,813
2.7
Patel Ajay SVP and CAO Officer
Transaction date
Purchase
Price
1.53
Quantity 8,170 +81.5%
Value US$12,500
3.3
Schwichtenberg Paul SVP and CFO Officer
Transaction date
Purchase
Price
1.51
Quantity 9,750 +70.8%
Value US$14,762
3.3
Peisert Daniel A. President and CEO Executive Director
Transaction date
Purchase
Price
1.54
Quantity 15,909 +21.6%
Value US$24,500
3.6
CR Group L.P. Large shareholder
Transaction date
Sale
Price
0.37
Quantity 1,982,851 -90.8%
Value US$730,086
3.6
CR Group L.P. Large shareholder
Transaction date
Sale
Price
0.37
Quantity 6,784,334 -75.7%
Value US$2,540,733
3.6
CR Group L.P. Large shareholder
Transaction date
Sale
Price
0.34
Quantity 1,500,000 -14.3%
Value US$508,500
3.6
CR Group L.P. Large shareholder
Transaction date
Sale
Price
0.36
Quantity 500,000 -4.6%
Value US$180,100
3.6
CR Group L.P. Large shareholder
Transaction date
Sale
Price
0.38
Quantity 500,000 -4.4%
Value US$188,800
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-12 2025-11-10 PlS Planned sale
Stark David Matthew
Non-Executive Director
50,974 +0.4%
219.41
US$3,945,441 		50,974 +0.4% 219.41 US$3,945,441
2025-11-10 2025-11-10 PrS Proposed sale
DAVID STARK

Director

Non-Executive Director
73,023
55.51
US$256,302 		73,023 55.51 US$256,302
2024-11-19 2024-11-18 B Purchase
4.0
Mason Heather L
Non-Executive Director
90,680 +16.4%
374.93
US$848,751 		90,680 +16.4% 374.93 US$848,751
2024-11-15 2024-11-14 B Purchase
2.2
O'Grady Brendan P.

CEO

Executive Director
11,706 New position
0.85
US$9,950 		11,706 New position 0.85 US$9,950
2024-06-12 2024-06-11 B Purchase
3.7
Vacirca Jeff L
Non-Executive Director
10,000 +7.1%
1.11
US$11,100 		10,000 +7.1% 1.11 US$11,100
2024-06-06 2024-06-05 B Purchase
4.0
Mason Heather L

Interim Executive Officer

Executive Director
25,000 +13.3%
0.97
US$24,250 		25,000 +13.3% 0.97 US$24,250
2024-03-15 2024-03-14 S Sale
3.3
Tyree James L
Non-Executive Director
10,251 -5.2%
1.12
US$11,463 		10,251 -5.2% 1.12 US$11,463
2024-03-14 2024-03-14 PrS Proposed sale
3.3
Tyree James L

Director

Non-Executive Director
10,251
1.12
US$11,463 		10,251 1.12 US$11,463
2023-09-13 2023-09-12 S Sale
3.3
Peisert Daniel A.

President & CEO

Executive Director
31,121 -8.7%
2.97
US$92,432 		31,121 -8.7% 2.97 US$92,432
2023-09-12 2023-09-12 PrS Proposed sale
3.3
Daniel A Peisert

Officer

Officer
31,121
3.01
US$93,674 		31,121 3.01 US$93,674
2023-09-13 2023-09-11 S Sale
3.3
Schlessinger Sam

SVP, General Counsel

Officer
45,236 -39.6%
3.04
US$137,441 		45,236 -39.6% 3.04 US$137,441
2023-09-13 2023-09-11 S Sale
3.3
Schwichtenberg Paul

SVP and CFO

Officer
104,980 -62.0%
3.07
US$322,593 		104,980 -62.0% 3.07 US$322,593
2023-09-13 2023-09-11 S Sale
2.7
Patel Ajay

SVP and CAO

Officer
64,313 -40.7%
3.04
US$195,794 		64,313 -40.7% 3.04 US$195,794
2023-09-13 2023-09-11 S Sale
3.3
Peisert Daniel A.

President & CEO

Executive Director
127,281 -26.3%
3.04
US$386,972 		127,281 -26.3% 3.04 US$386,972
2023-09-11 2023-09-11 PrS Proposed sale
2.7
Patel Ajay

Officer

Officer
64,313
3.17
US$203,872 		64,313 3.17 US$203,872
2023-09-11 2023-09-11 PrS Proposed sale
3.3
SAM SCHLESSINGER

Officer

Officer
45,236
3.04
US$137,441 		45,236 3.04 US$137,441
2023-09-11 2023-09-11 PrS Proposed sale
3.3
DANIEL PEISERT

Officer

Officer
127,281
3.04
US$386,972 		127,281 3.04 US$386,972
2023-09-11 2023-09-11 PrS Proposed sale
3.3
PAUL SCHWICHTENBERG

Officer

Officer
104,980
3.07
US$322,593 		104,980 3.07 US$322,593
2023-08-15 2023-08-14 PlS Planned sale
MCKEE WILLIAM
Non-Executive Director
22,000 -8.4%
3.14
US$69,045 		22,000 -8.4% 3.14 US$69,045
2023-08-14 2023-08-14 PrS Proposed sale
WILLIAM MCKEE

Director

Non-Executive Director
22,000
3.14
US$69,045 		22,000 3.14 US$69,045
2023-05-22 2023-05-19 S Sale
4.0
Mason Heather L
Non-Executive Director
89,286 -32.2%
7.30
US$652,011 		89,286 -32.2% 7.30 US$652,011
2023-05-19 2023-05-19 PrS Proposed sale
4.0
Mason Heather L

Director

Non-Executive Director
89,286
7.30
US$651,788 		89,286 7.30 US$651,788
2023-05-05 2023-05-05 PrS Proposed sale
3.3
JAMES TYREE

Director

Non-Executive Director
43,143
6.00
US$258,767 		43,143 6.00 US$258,767
2023-05-05 2023-05-05 PlS Planned sale
3.3
Tyree James L
Non-Executive Director
43,143 -20.5%
6.00
US$258,767 		43,143 -20.5% 6.00 US$258,767
2022-05-16 2022-05-12 PlS Planned sale
MCKEE WILLIAM
Non-Executive Director
22,322 -8.9%
2.35
US$52,488 		22,322 -8.9% 2.35 US$52,488
2022-05-16 2022-05-12 PlS Planned sale
3.3
Tyree James L
Non-Executive Director
44,643 -17.5%
2.36
US$105,170 		44,643 -17.5% 2.36 US$105,170
2022-04-13 2022-04-11 PlS Planned sale
3.3
Peisert Daniel A.

President and CEO

Executive Director
26,391 -14.3%
3.50
US$92,368 		26,391 -14.3% 3.50 US$92,368
2022-04-07 2022-04-05 PlS Planned sale
3.3
Peisert Daniel A.

President and CEO

Executive Director
34,518 -15.7%
3.50
US$120,813 		34,518 -15.7% 3.50 US$120,813
2021-05-24 2021-05-20 B Purchase
2.7
Patel Ajay

SVP and CAO

Officer
8,170 +81.5%
1.53
US$12,500 		8,170 +81.5% 1.53 US$12,500
2021-05-24 2021-05-20 B Purchase
3.3
Schwichtenberg Paul

SVP and CFO

Officer
9,750 +70.8%
1.51
US$14,762 		9,750 +70.8% 1.51 US$14,762
2021-05-24 2021-05-20 B Purchase
3.3
Peisert Daniel A.

President and CEO

Executive Director
15,909 +21.6%
1.54
US$24,500 		15,909 +21.6% 1.54 US$24,500
2020-12-29 2020-12-24 S Sale
3.6
CR Group L.P.
Large shareholder
1,982,851 -90.8%
0.37
US$730,086 		1,982,851 -90.8% 0.37 US$730,086
2020-12-29 2020-12-23 S Sale
3.6
CR Group L.P.
Large shareholder
6,784,334 -75.7%
0.37
US$2,540,733 		6,784,334 -75.7% 0.37 US$2,540,733
2020-12-22 2020-12-22 S Sale
3.6
CR Group L.P.
Large shareholder
1,500,000 -14.3%
0.34
US$508,500 		1,500,000 -14.3% 0.34 US$508,500
2020-12-22 2020-12-21 S Sale
3.6
CR Group L.P.
Large shareholder
500,000 -4.6%
0.36
US$180,100 		500,000 -4.6% 0.36 US$180,100
2020-12-22 2020-12-18 S Sale
3.6
CR Group L.P.
Large shareholder
500,000 -4.4%
0.38
US$188,800 		500,000 -4.4% 0.38 US$188,800
Explore more

More insider trading research around Assertio Holdings Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America